When

Tuesday, September 20, 2022 from 6:00 PM to 8:00 PM EDT

Where

Maguire Center at Westminster Oaks 
4449 Meandering Way, Tallahassee, FL 32308

Contact
Rosalie Carlin, Capital Medical Society
850-877-9018    rcarlin@capmed.org
__________________________________________

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Florida Medical Association and Capital Medical Society.  The Florida Medical Association is accredited by the ACCME to provide continuing medical education for physicians.

The Florida Medical Association designates this live activity for a maximum of
one (1.0) AMA PRA Category 1 Credits
Physicians should claim only the credit
commensurate with the extent of their participation in the activity.

 

 


 


 

 

 

 



 

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The planners of this activity disclosed no financial relationships with ineligible companies whose primary business
is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients, with the
exception of Winston Ortiz, M.D. Dr. Ortiz disclosed that he is member of the speaker’s bureau for Allergan and TEVA.

Dr. Danny Estupiñán, speaker for this educational event, has no relevant financial relationships with ineligible
companies to disclose.

All of the relevant financial relationships listed for these individuals have been mitigated.

Registration Deadline:  September 14, 2022
Dinner Included
You will be asked to select you meal in registration form.

Learning Objectives:

Learn about new migraine treatments now available.
Apply treatment criteria for acute and preventative
treatments for migraine.
Touch on future of migraine treatment.